Abstract
Free full text
Presumed Asymptomatic Carrier Transmission of COVID-19
This study describes possible transmission of novel coronavirus disease 2019 (COVID-19) from an asymptomatic Wuhan resident to 5 family members in Anyang, a Chinese city in the neighboring province of Hubei.
A novel coronavirus has resulted in an ongoing outbreak of viral pneumonia in China.1,2,3 Person-to-person transmission has been demonstrated,1 but, to our knowledge, transmission of the novel coronavirus that causes coronavirus disease 2019 (COVID-19) from an asymptomatic carrier with normal chest computed tomography (CT) findings has not been reported.
Methods
In January 2020, we enrolled a familial cluster of 5 patients with fever and respiratory symptoms who were admitted to the Fifth People’s Hospital of Anyang, Anyang, China, and 1 asymptomatic family member. This study was approved by the local institutional review board, and written informed consent was obtained from all patients. A detailed analysis of patient records was performed.
All patients underwent chest CT imaging. Real-time reverse transcriptase polymerase chain reaction (RT-PCR) tests for COVID-19 nucleic acid were performed using nasopharyngeal swabs (Novel Coronavirus PCR Fluorescence Diagnostic Kit, BioGerm Medical Biotechnology).
Results
Patient 1 (presumed asymptomatic carrier), a 20-year-old woman, lives in Wuhan and traveled to Anyang on January 10, 2020. She initially met with patients 2 and 3 on January 10. On January 13, she accompanied 5 relatives (patients 2 through 6) to visit another hospitalized relative in Anyang District Hospital (Figure). There was no report of COVID-19 at this hospital. After development of disease in her relatives, patient 1 was isolated and observed. As of February 11, she had no elevated temperature measured or self-reported fever and no gastrointestinal or respiratory symptoms, including cough and sore throat, reported or observed by the physicians. Chest CT images on January 27 and 31 showed no significant abnormalities. Her C-reactive protein level and lymphocyte count were normal (Table). Results of RT-PCR testing were negative on January 26, positive on January 28, and negative on February 5 and 8.
Table.
Reference range | Patient 1a | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Patient 6 | |
---|---|---|---|---|---|---|---|
C-reactive protein, mg/L | 0.0-4.0 | 0.69 | 217.17 | 10.14 | 66.07 | 14.9 | 202.03 |
Eosinophils, ×109/L | 0.02-0.52 | 0.02 | 0 | 0.01 | 0 | 0 | 0 |
Eosinophil ratios, % | 0.4-8 | 0.40 | 0 | 0.30 | 0 | 0.10 | 0 |
Lymphocytes, ×109/L | 1.1-3.2 | 1.55 | 0.53 | 1.65 | 0.91 | 0.46 | 0.69 |
Lymphocyte ratios, % | 20-50 | 27.50 | 6.70 | 35.90 | 27.70 | 13.30 | 7.40 |
Neutrophils, ×109/L | 1.8-6.3 | 3.62 | 6.89 | 2.64 | 2.10 | 2.89 | 8.21 |
Neutrophil ratios, % | 40-75 | 63.90 | 86.40 | 57.40 | 64.00 | 84.10 | 87.00 |
White blood cell count, ×109/L | 3.9-9.9 | 5.65 | 7.97 | 4.59 | 3.29 | 3.44 | 9.43 |
Patients 2 through 6 developed COVID-19. Four were women, and ages ranged from 42 to 57 years. None of the patients had visited Wuhan or been in contact with any other people who had traveled to Wuhan (except patient 1).
Patients 2 through 5 developed fever and respiratory symptoms between January 23 and January 26 and were admitted to the hospital on the same day. All patients had RT-PCR test results positive for COVID-19 within 1 day. Patient 6 developed fever and sore throat on January 17 and went to the local clinic for treatment. There was no report of COVID-19 at the clinic. Her symptoms improved over the next few days but worsened on January 24, when she was admitted to the hospital and confirmed to have COVID-19 on January 26. Two patients developed severe pneumonia; the other infections were moderate.
All symptomatic patients had multifocal ground-glass opacities on chest CT, and 1 also had subsegmental areas of consolidation and fibrosis. All the symptomatic patients had increased C-reactive protein levels and reduced lymphocyte counts (Table).
Discussion
A familial cluster of 5 patients with COVID-19 pneumonia in Anyang, China, had contact before their symptom onset with an asymptomatic family member who had traveled from the epidemic center of Wuhan. The sequence of events suggests that the coronavirus may have been transmitted by the asymptomatic carrier. The incubation period for patient 1 was 19 days, which is long but within the reported range of 0 to 24 days.4 Her first RT-PCR result was negative; false-negative results have been observed related to the quality of the kit, the collected sample, or performance of the test. RT-PCR has been widely deployed in diagnostic virology and has yielded few false-positive outcomes.5 Thus, her second RT-PCR result was unlikely to have been a false-positive and was used to define infection with the coronavirus that causes COVID-19.
One previous study reported an asymptomatic 10-year-old boy with COVID-19 infection, but he had abnormalities on chest CT.6 If the findings in this report of presumed transmission by an asymptomatic carrier are replicated, the prevention of COVID-19 infection would prove challenging. The mechanism by which asymptomatic carriers could acquire and transmit the coronavirus that causes COVID-19 requires further study.
Notes
Section Editor: Jody W. Zylke, MD, Deputy Editor.
References
Full text links
Read article at publisher's site: https://doi.org/10.1001/jama.2020.2565
Read article for free, from open access legal sources, via Unpaywall: https://jamanetwork.com/journals/jama/articlepdf/2762028/jama_bai_2020_ld_200013.pdf
Citations & impact
Impact metrics
Article citations
Design and psychometrics of a tool for measuring social cognitive factors related to the preventive behaviors toward Covid-19 in the society.
Sci Rep, 14(1):27494, 11 Nov 2024
Cited by: 0 articles | PMID: 39528706 | PMCID: PMC11555316
Controlling the first wave of the COVID-19 pandemic in Malawi: Results from a multi-round study.
PLOS Glob Public Health, 4(10):e0003474, 24 Oct 2024
Cited by: 0 articles | PMID: 39446835 | PMCID: PMC11500973
Synthetic vs. natural antimicrobial agents for safer textiles: a comparative review.
RSC Adv, 14(42):30688-30706, 26 Sep 2024
Cited by: 0 articles | PMID: 39328870 | PMCID: PMC11425080
Review Free full text in Europe PMC
Estimating population infection rates from non-random testing data: Evidence from the COVID-19 pandemic.
PLoS One, 19(9):e0311001, 26 Sep 2024
Cited by: 0 articles | PMID: 39325815 | PMCID: PMC11426536
Nanoscale hyperthermia mesostructures for sustainable antimicrobial design.
Cell Rep Phys Sci, 5(7):102081, 08 Jul 2024
Cited by: 0 articles | PMID: 39092206 | PMCID: PMC11293369
Go to all (2,064) article citations
Other citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
High proportion of asymptomatic and presymptomatic COVID-19 infections in air passengers to Brunei.
J Travel Med, 27(5):taaa066, 01 Aug 2020
Cited by: 31 articles | PMID: 32365178 | PMCID: PMC7239182
[Advances on presymptomatic or asymptomatic carrier transmission of COVID-19].
Zhonghua Liu Xing Bing Xue Za Zhi, 41(4):485-488, 01 Apr 2020
Cited by: 26 articles | PMID: 32141279
A confirmed asymptomatic carrier of 2019 novel coronavirus.
Chin Med J (Engl), 133(9):1123-1125, 01 May 2020
Cited by: 34 articles | PMID: 32149768 | PMCID: PMC7213620
An Asymptomatic Patient with COVID-19.
Am J Respir Crit Care Med, 201(11):1428-1429, 01 Jun 2020
Cited by: 3 articles | PMID: 32315543 | PMCID: PMC7258648